Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer
Aging2019Vol. 11(2), pp. 480–500
Citations Over TimeTop 1% of 2019 papers
Peng Lin, Yinan Guo, Lin Shi, Xiao‐Jiao Li, Hong Yang, Yun He, Qing Li, Yi‐Wu Dang, Kang‐Lai Wei, Gang Chen
Abstract
Together, our results screened several IRGs of clinical significance, revealed drivers of the immune repertoire, and demonstrated the importance of a personalized, IRG-based immune signature in the recognition, surveillance, and prognosis of PTC.
Related Papers
- → Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013(2017)2,150 cited
- → Thyroid Cancer Screening in South Korea Increases Detection of Papillary Cancers with No Impact on Other Subtypes or Thyroid Cancer Mortality(2016)213 cited
- → Lessons from Mouse Models of Thyroid Cancer(2009)52 cited
- → CDK12 promotes papillary thyroid cancer progression through regulating the c-myc/β-catenin pathway(2020)20 cited
- → Modern aspects influencing the management of patients with papillary thyroid cancer(2023)3 cited